These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16924691)

  • 1. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
    Neogi T; Gladman DD; Ibanez D; Urowitz M
    J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
    Kim KH; Han JY; Kim JM; Lee SW; Chung WT
    Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
    Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
    Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
    Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
    Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of indirect immunofluorescence on Crithidia luciliae of Farr test, and immunoenzymatic methods for the screening of anti-native DNA autoantibodies].
    Chrétien P; Dauvin M; Hélin P; Ocwieja T; Absalon YB; Johanet C
    Ann Biol Clin (Paris); 1994; 52(9):645-50. PubMed ID: 7872513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.
    Venner AA; Ibañez D; Gladman DD; Urowitz MB; MacKinnon A; Blasutig IM; Yip PM
    Clin Biochem; 2013 Mar; 46(4-5):317-20. PubMed ID: 23246539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC; Ho LY; Leung HW; Wong LG
    Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
    Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
    Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies.
    Radice A; Sinico RA
    Autoimmunity; 2006 Mar; 39(2):113-9. PubMed ID: 16698667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparison of the three anti-dsDNA antibody detecting test].
    Tong DW; Zhang SL; Li YZ; Hu CJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):74-5. PubMed ID: 19799026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus.
    Launay D; Schmidt J; Lepers S; Mirault T; Lambert M; Kyndt X; Reumaux D; Duhamel A; Hachulla E; Hatron PY; Prin L; Dubucquoi S
    Clin Chim Acta; 2010 Jul; 411(13-14):959-64. PubMed ID: 20303931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP; Manson JJ; Rahman A; Isenberg DA
    Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.